Avirmax CMC Inc. Received License for cGMP Gene Therapy Vector Production by the California Department of Public Health
HAYWARD, Calif., Oct. 31, 2022 /PRNewswire/ -- Avirmax CMC Inc., a global leader in recombinant adeno associate virus vector (rAAV) innovation and...
Source: businessinsider.com